Skip to main content
. 2023 May 18;13:1180988. doi: 10.3389/fonc.2023.1180988

Table 3.

Treatment related adverse events.

Toxicity All grades n (%) G3-4 n (%)
Fatigue 9 (21%) 2 (5%)
Skin reactions (including HFS) 6 (14%) 2 (5%)
Diarrhea 6 (14%) 1 (2%)
Hypertension 5 (12%) 2 (5%)
Proteinuria 4 (10%) 3 (7%)
Rheumatologic toxicity 3 (7%) 1 (2%)
Elevated LFTs 2 (5%) 0 (0%)
Anemia 1 (2%) 1 (2%)
Perforation 1 (2%) 1 (2%)

G3-4, Grade 3-4; LFTs, liver function tests; HFS, hand & foot syndrome.